News

With influenza B making a late-season rise, health officials are warning that B viruses may cause a second wave of flu this season, while the FDA is backing some alternatives to egg-based flu vaccines.

Based on current projections, antibiotic consumption could increase by as much as 200% by 2030.

This comes on the heels of 2 recent FDA approvals of 2 Mylan antiretrovirals: Cimduo and Symfi Lo.

Antibiotics are the mainstay treatment for CAP; however, the additive role of corticosteroids is continually being debated.

Culture-independent diagnostic tests offer better food-borne infection incidence estimates, but without isolates, laboratories are unable to subtype pathogens, determine antimicrobial susceptibility, and detect outbreaks.

The first documentation of the east Asian tick Haemaphysalis longicornis in the United States has been described in a recent study.

A recent study explores the use of isavuconazole for prophylaxis against invasive fungal infections in allogeneic stem cell transplant patients.

As the leading cause of unplanned 30-day hospital readmissions, sepsis affects more than 1.5 million individuals each year.

A recent study finds that daily antituberculosis therapy is more effective than a thrice-weekly regimen among HIV-positive patients with pulmonary tuberculosis.

The vaccine reduced the risk of herpes zoster by 68.2% in high-risk recipients of hematopoietic stem cell transplant.

A new study finds that a 1-month course of antibiotics is as safe & effective as the commonly recommended 9-month course in preventing tuberculosis in those with HIV.

In case you missed them, we’ve compiled a list of the latest recalls posted this week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

In light of World TB Day, the CDC has released provisional TB surveillance data indicating a decline in cases in the United States, but at a rate that’s too slow to achieve elimination in this century.

Positive safety and efficacy results have been seen across 2 different dosing regimens as well as for any effects on QT prolongation.

Research presented at the 47th Critical Care Congress reveals that PCT-guided antibiotic cessation in critically ill patients resulted in reduced mortality.

As an outbreak of Lassa fever in Nigeria continues to spread, the Coalition for Epidemic Preparedness Innovations is working with Themis Bioscience to develop a vaccine to protect against the virus.

A new study suggests that an antiretroviral combination of dolutegravir with darunavir/cobicistat can be prescribed safely in the treatment of HIV-1.

AIDS researcher Robert Redfield, MD, has officially been named the new director of the CDC.

The program can detect viral hemorrhagic fevers about 12 days faster than previous efforts.

The CDC has announced that they are investigating yet another multistate outbreak of Salmonella, this time, linked to dried coconut product.

The National Center for Health Statistics has released new data on flu vaccination rates in the United States, as 1 new study shows which airline passengers may be at greatest risk of catching the flu inflight.

Investigators from the Centers for Disease Control and Prevention have determined the incidence of carbapenem-resistant Acinetobacter baumannii and "the basic epidemiology” of infections caused by these isolates in 8 metro areas.

In the dollars and cents of health security, funding towards the Global Health Security Agenda is a smart investment.

The first reports of H7N9 infection amongst humans occurred in China in 2013.

The number of individuals infected with Listeria continues to grow in South Africa, as officials identify the source responsible.

Falsified hepatitis B vaccines were discovered at 8 health facilities in Uganda.

Implementation of a rapid entry program decreased time to first provider appointment, time to initiation of ART, and time to viral suppression in the Southern United States.